Senior Director, Translational Medicine and Clinical Biomarkers at Nurix Therapeutics, owning biomarker strategy across the company's oncology and immunology clinical portfolio. The role sets priorities for patient stratification, response prediction, and resistance-mechanism research, directly informing trial design and dosing decisions across multiple concurrent clinical programs.
Text as published by the employer. Always confirm details on the employer's site.